What is Mobic and how is it used. How should Mobic be taken. What are the potential side effects of Mobic. Can Mobic interact with other medications. Is Mobic safe during pregnancy and breastfeeding.

Understanding Mobic: An Overview of Meloxicam

Mobic, known generically as meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID) widely prescribed for managing pain and inflammation associated with various conditions. This medication plays a crucial role in treating osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis.

How does Mobic work? It primarily functions by reducing the production of prostaglandins, chemicals in the body responsible for pain and inflammation. By inhibiting these substances, Mobic helps alleviate discomfort and improve mobility in patients suffering from arthritic conditions.

Dosage Guidelines for Mobic: Tailoring Treatment to Patient Needs

Determining the right dosage of Mobic is essential for effective treatment while minimizing potential side effects. Healthcare providers typically follow these general dosing instructions:

• Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals
• The maximum recommended daily oral dose for adults is 15 mg, regardless of formulation
• For patients on hemodialysis, the maximum daily dosage is 7.5 mg
• Mobic can be taken without regard to timing of meals

Osteoarthritis Dosage

For osteoarthritis treatment, the recommended starting and maintenance oral dose is 7.5 mg once daily. Some patients may benefit from increasing the dose to 15 mg once daily if needed.

Rheumatoid Arthritis Dosage

Similar to osteoarthritis, the recommended starting and maintenance oral dose for rheumatoid arthritis is 7.5 mg once daily, with the option to increase to 15 mg once daily if necessary.

Juvenile Rheumatoid Arthritis Dosage

For children with juvenile rheumatoid arthritis, the recommended oral dose is 0.125 mg/kg once daily, up to a maximum of 7.5 mg. The use of Mobic oral suspension is recommended for more accurate dosing in smaller weight children.

Mobic Formulations: Understanding the Options

Mobic is available in various formulations to suit different patient needs and preferences:

• Oral tablets: 7.5 mg and 15 mg strengths
• Oral suspension: 7.5 mg/5 mL concentration

Is the oral suspension interchangeable with tablets? It’s important to note that Mobic oral suspension has not shown equivalent systemic exposure to other approved formulations of oral meloxicam. Therefore, it is not interchangeable with other formulations of oral meloxicam products, even if the total milligram strength is the same.

Potential Side Effects and Precautions

While Mobic can be highly effective in managing pain and inflammation, it’s crucial to be aware of potential side effects and take necessary precautions:

• Gastrointestinal issues: stomach pain, nausea, vomiting, or diarrhea
• Cardiovascular risks: increased risk of heart attack or stroke, especially with long-term use
• Kidney problems: reduced kidney function or kidney damage in some cases
• Allergic reactions: skin rash, itching, or swelling

Are there any specific populations that should exercise caution when using Mobic? Patients with a history of gastrointestinal bleeding, heart disease, or kidney problems should consult their healthcare provider before starting Mobic. Additionally, elderly patients may be at higher risk for certain side effects and may require closer monitoring.

Drug Interactions: Navigating Potential Risks

Understanding potential drug interactions is crucial when taking Mobic. The medication is known to interact with 379 drugs, including:

• 95 major interactions
• 278 moderate interactions
• 6 minor interactions

Which common medications might interact with Mobic? Some notable interactions include:

1. Other NSAIDs: Increased risk of gastrointestinal side effects
2. Blood thinners: Increased risk of bleeding
3. Certain antidepressants: Potential for increased bleeding risk
4. ACE inhibitors and ARBs: Possible reduction in blood pressure-lowering effects
5. Diuretics: Potential for reduced effectiveness and increased risk of kidney problems

To ensure safety, patients should always inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting Mobic.

Mobic in Special Populations: Pregnancy, Breastfeeding, and Renal Impairment

Special considerations are necessary when prescribing Mobic to certain patient populations:

Pregnancy and Breastfeeding

Is Mobic safe during pregnancy? The use of Mobic during pregnancy, especially in the third trimester, is generally not recommended due to potential risks to the fetus. Breastfeeding mothers should also consult their healthcare provider before using Mobic, as it may pass into breast milk.

Renal Impairment

How does renal function affect Mobic dosing? In patients with severe renal impairment, the use of Mobic is not recommended. For patients on hemodialysis, the maximum dosage is limited to 7.5 mg per day. Regular monitoring of kidney function is essential for patients with any degree of renal impairment who are prescribed Mobic.

Comparing Mobic to Other Pain Medications

When considering pain management options, it’s helpful to understand how Mobic compares to other commonly used medications:

Mobic vs. Ibuprofen

How do Mobic and ibuprofen differ? While both are NSAIDs, Mobic typically has a longer duration of action, allowing for once-daily dosing. Ibuprofen, on the other hand, is often taken multiple times a day. Mobic may also have a lower risk of gastrointestinal side effects compared to ibuprofen.

Mobic vs. Celebrex

Are Mobic and Celebrex similar? Both medications are NSAIDs used for treating arthritis pain, but Celebrex is a COX-2 selective inhibitor, which may offer a lower risk of gastrointestinal side effects. However, both medications carry similar cardiovascular risks.

Mobic with Other Pain Relievers

Can Mobic be taken with other pain medications? While it’s generally not recommended to combine NSAIDs, some patients may be able to take Mobic with acetaminophen (Tylenol) under the guidance of their healthcare provider. However, combining Mobic with other NSAIDs like naproxen (Aleve) is typically not advised due to increased risk of side effects.

Frequently Asked Questions About Mobic

To address common concerns and provide clarity on Mobic use, here are answers to frequently asked questions:

Timing of Mobic Administration

Should Mobic be taken at night or in the morning? Mobic can be taken at any time of day, with or without food. However, taking it at the same time each day can help maintain consistent blood levels of the medication. Some patients find taking it in the morning helps manage daytime pain, while others prefer nighttime administration to alleviate morning stiffness.

Mobic and Drowsiness

Can Mobic cause drowsiness? While drowsiness is not a common side effect of Mobic, some patients may experience fatigue or dizziness. If these effects occur, it’s important to avoid driving or operating machinery until you know how the medication affects you.

Mobic for Gout Treatment

Is Mobic effective for gout? While Mobic is primarily used for osteoarthritis and rheumatoid arthritis, it may also be prescribed for acute gout attacks. However, other medications like colchicine or corticosteroids are often preferred as first-line treatments for gout.

Mobic Classification

Is Mobic a narcotic or a sulfa drug? Mobic is neither a narcotic nor a sulfa drug. It is a nonsteroidal anti-inflammatory drug (NSAID) and does not have the addictive properties associated with narcotics. Additionally, it does not contain sulfonamides, making it safe for most patients with sulfa allergies.

Understanding Mobic’s uses, dosage guidelines, potential side effects, and interactions is crucial for safe and effective use of this medication. Patients should always consult their healthcare provider for personalized advice and guidance on using Mobic as part of their treatment plan.

Mobic Dosage Guide – Drugs.com

Print

Save

Generic name: MELOXICAM 7.5mg in 5mL
Dosage form: oral suspension
Drug class: Nonsteroidal anti-inflammatory drugs

Medically reviewed by Drugs.com. Last updated on Sep 5, 2022.

General Dosing Instructions

Carefully consider the potential benefits and risks of MOBIC and other treatment options before deciding to use MOBIC. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)].

After observing the response to initial therapy with MOBIC, adjust the dose to suit an individual patient’s needs.

In adults, the maximum recommended daily oral dose of MOBIC is 15 mg regardless of formulation. In patients with hemodialysis, a maximum daily dosage of 7.5 mg is recommended [see Use in Specific Populations (8.7) and Clinical Pharmacology (12.3)].

MOBIC oral suspension 7.5 mg/5 mL or 15 mg/10 mL may be substituted for MOBIC tablets 7. 5 mg or 15 mg, respectively.

Shake the oral suspension gently before using.

MOBIC may be taken without regard to timing of meals.

Osteoarthritis

For the relief of the signs and symptoms of osteoarthritis the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.

Rheumatoid Arthritis

For the relief of the signs and symptoms of rheumatoid arthritis, the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.

Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course

To improve dosing accuracy in smaller weight children, the use of the MOBIC oral suspension is recommended. MOBIC oral suspension is available in the strength of 7.5 mg/5 mL. For the treatment of juvenile rheumatoid arthritis, the recommended oral dose of MOBIC is 0. 125 mg/kg once daily up to a maximum of 7.5 mg. There was no additional benefit demonstrated by increasing the dose above 0.125 mg/kg once daily in these clinical trials.

Juvenile Rheumatoid Arthritis dosing using the oral suspension should be individualized based on the weight of the child:

Renal Impairment

The use of MOBIC in subjects with severe renal impairment is not recommended.

In patients on hemodialysis, the maximum dosage of MOBIC is 7.5 mg per day [see Clinical Pharmacology (12. 3)].

Non-Interchangeability with Other Formulations of Meloxicam

MOBIC Suspension has not shown equivalent systemic exposure to other approved formulations of oral meloxicam. Therefore, MOBIC Suspension is not interchangeable with other formulations of oral meloxicam product even if the total milligram strength is the same. Do not substitute similar dose strengths of MOBIC Suspension with other formulations of oral meloxicam product.

Frequently asked questions

• Meloxicam vs Ibuprofen, what’s the difference?
• Can I take Meloxicam and Aleve or Tylenol together?
• Which painkiller should you use?
• Should I take meloxicam at night or in the morning?
• Can antidepressants be used for arthritis pain?
• How long do I wait after taking ibuprofen to take meloxicam?
• Is meloxicam very similar to Celebrex?
• Can meloxicam cause drowsiness and headache?
• Is meloxicam a narcotic?
• Is meloxicam helpful in gout treatment?
• Is meloxicam a sulfa drug?

More about Mobic (meloxicam)

• Check interactions
• Compare alternatives
• Reviews (133)
• Drug images
• Latest FDA alerts (5)
• Side effects
• During pregnancy
• Generic availability
• Support group
• Drug class: Nonsteroidal anti-inflammatory drugs
• Breastfeeding
• En español

Patient resources

• Drug Information
• Mobic (Meloxicam Suspension)
• Mobic (Meloxicam Tablets)

Other brands

Anjeso, Vivlodex, Qmiiz ODT

Professional resources

• Prescribing Information

Related treatment guides

• Osteoarthritis
• Rheumatoid Arthritis
• Juvenile Rheumatoid Arthritis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Mobic Interactions Checker – Drugs.com

Print

Save

There are 379 drugs known to interact with
Mobic (meloxicam), along with
12 disease interactions, and 3 alcohol/food interactions.

Of the total drug interactions,
95 are major, 278 are moderate, and 6 are minor.

Does Mobic interact with my other drugs?

Enter other medications to view a detailed report.

• View all 379 medications that may interact with Mobic
• View Mobic alcohol/food interactions (3)
• View Mobic disease interactions (12)

Most frequently checked interactions

View interaction reports for Mobic (meloxicam) and the medicines listed below.

• Major
• Moderate
• Minor
• Unknown

• albuterol
• Ambien (zolpidem)
• aspirin
• Cymbalta (duloxetine)
• Flexeril (cyclobenzaprine)
• gabapentin
• hydrochlorothiazide
• Klonopin (clonazepam)
• levothyroxine
• Lexapro (escitalopram)
• Lipitor (atorvastatin)
• lisinopril
• Lyrica (pregabalin)
• metformin
• Neurontin (gabapentin)
• Nexium (esomeprazole)
• Norco (acetaminophen / hydrocodone)
• omeprazole
• prednisone
• Prilosec (omeprazole)
• Singulair (montelukast)
• Synthroid (levothyroxine)
• Topamax (topiramate)
• tramadol
• trazodone
• Vitamin B12 (cyanocobalamin)
• Vitamin D3 (cholecalciferol)
• Xanax (alprazolam)
• Zoloft (sertraline)
• Zyrtec (cetirizine)

Mobic alcohol/food interactions

There are 3 alcohol/food interactions with Mobic (meloxicam).

Mobic disease interactions

There are 12 disease interactions with Mobic (meloxicam) which include:

• asthma
• fluid retention
• GI toxicity
• rash
• renal toxicities
• thrombosis
• anemia
• heart failure
• hepatotoxicity
• hyperkalemia
• hypertension
• platelet aggregation inhibition

Report options

Loading…

QR code containing a link to this page

More about Mobic (meloxicam)

• Mobic consumer information
• Compare alternatives
• Reviews (133)
• Drug images
• Latest FDA alerts (5)
• Side effects
• Dosage information
• During pregnancy
• Generic availability
• Support group
• Drug class: Nonsteroidal anti-inflammatory drugs
• Breastfeeding
• En español

Related treatment guides

• Osteoarthritis
• Rheumatoid Arthritis
• Juvenile Rheumatoid Arthritis

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.

Major	Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate	Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor	Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown	No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Motrin® tablets 250 mg – 10 and 20 pieces for pain and inflammation up to 12 hours, prices

to <1/10), infrequently (≥1/1000 to <1/100), rare (≥1/10,000 to <1/1000), very rare (<1/10,000), frequency unknown (not can be estimated based on available data).

The most frequently observed adverse reactions were from the gastrointestinal tract. It is possible to develop a peptic ulcer, gastric perforation or gastrointestinal bleeding, sometimes fatal, especially in elderly patients (see section “Special Instructions”).

Within each group, HPs are listed in descending order of severity.

Blood and lymphatic system disorders:

Uncommon: Eosinophilia, granulocytopenia, leukopenia, thrombocytopenia.

Nervous system disorders:

often: headache, vertigo, dizziness, drowsiness;

infrequently: depression, sleep disturbance, impaired concentration, insomnia, malaise.

Visual disturbances:

common: visual impairment.

Hearing and labyrinth disorders:

often : tinnitus, hearing impairment;

Uncommon: hearing loss.

Cardiac disorders:

common: swelling, palpitations;

Uncommon: congestive heart failure.

Respiratory, thoracic and mediastinal disorders:

often : shortness of breath;

infrequently : eosinophilic pneumonia.

Gastrointestinal disorders:

often: constipation, abdominal pain, dyspepsia, nausea, diarrhoea, stomatitis, flatulence;

infrequently: gastrointestinal bleeding and / or gastric perforation, hematemesis, melena, vomiting;

very rare : relapse or worsening of ulcerative colitis or Crohn’s disease;

frequency unknown : gastritis.

Liver and biliary tract disorders:

infrequently: increased activity of “liver” enzymes, jaundice.

Skin and subcutaneous tissue disorders:

often : pruritus, skin rash, ecchymosis, purpura;

infrequently : alopecia, photodermatosis;

very rare : bullous reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

Musculoskeletal and connective tissue disorders:

infrequently : myalgia and muscle weakness.

Renal and urinary tract disorders:

Uncommon: glomerulonephritis, hematuria, interstitial nephritis, nephrotic syndrome, renal failure, renal papillary necrosis.

General disorders and administration site disorders:

often : thirst, increased sweating;

infrequently : hypersensitivity reactions, menstrual disorders, hyperthermia (chills and fever).

During therapy with non-steroidal anti-inflammatory drugs, edema and symptoms of heart failure, increased blood pressure were reported.